Coronavirus will slow down global drug development, says new survey
CAMBRIDGE, Mass. — New drugs need to be tested in clinical trials to be approved. However, a recent survey from Clinical Research IO shows that investigators conducting clinical trials on a wide range of diseases are experiencing significant interruptions in their trials due to the ongoing coronavirus crisis. 24% of investigators reported that they have
